Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial - 04/09/15
, Mohammad Amin Zare, MD a, Hamid Reza Bahmani, MD a, Shahriar Zehtabchi, MD bAbstract |
Objectives |
This randomized clinical trial compares the efficacy and safety of oral oxycodone (an oral opioid) with naproxen (a nonsteroidal anti-inflammatory drug) in acute pain control in patients with soft tissue injury. It also evaluates the need for additional doses of analgesics in the first 24 hours of discharge from emergency department (ED).
Methods |
Adult (>18 years old) patients with soft tissue injuries were enrolled in a teaching urban ED. Subjects were randomly allocated to receive a single dose of oral oxycodone (5 mg) or oral naproxen (250 mg). Pain scores and drugs' adverse effects were assessed before, 30 minutes, and 60 minutes after medication. Outcome: efficacy in pain control (reduction in pain scale >2 points) and safety (rate of side effects). The need for additional pain medication after discharge was assessed by follow-up phone call 24 hours after discharge.
Results |
A total of 150 patients were enrolled. Pain scores were similar in oxycodone vs naproxen groups before (6.21 ± 0.9 in vs 6.0 ± 1.0), 30 minutes (4.5 ± 1.4 vs 4.4 ± 1.2), and 60 minutes (2.5 ± 1.3 in vs 2.6 ± 1.3) after medication, respectively. Twelve (16.0%) patients in oral oxycodone group and 5 (6.6%) patients in naproxen group needed more analgesics in first 24 hours after ED discharge. Adverse effects were more common in oxycodone group (statistically significant difference). The most common adverse effects in oxycodone group were nausea, (13.3%); vomiting, (8.0%); dizziness, (5.3%); drowsiness, 3 (4.0%); and pruritis, (2.7%).
Conclusion |
Oral oxycodone is as effective as naproxen in soft tissue injury pain control but has a less favorable safety profile.
Le texte complet de cet article est disponible en PDF.Plan
| ☆ | Conflict of interest disclosure: All authors declare that they have no conflict of interest. |
| ☆☆ | Compliance with ethical requirements: This study was approved by institutional ethics committee, and written informed consent was obtained from all patients. Trial was registered at irct.ir (identifier: IRCT201112208104N3). |
| ★ | Funding statement: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. |
Vol 33 - N° 9
P. 1205-1208 - septembre 2015 Retour au numéro
Article précédent
- Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths
- Jessica Rando, Derek Broering, James E. Olson, Catherine Marco, Stephen B. Evans
- Inaccuracy of Thrombolysis in Myocardial Infarction and Global Registry in Acute Coronary Events scores in predicting outcome in ED patients with potential ischemic chest pain
- Hamdi Boubaker, Kaouther Beltaief, Mohamed Habib Grissa, Wièm Kerkeni, Zohra Dridi, Mohamed Amine Msolli, Hamdène Chouchène, Alia Belaïd, Hamadi Chouchène, Mohamed Sassi, Wahid Bouida, Riadh Boukef, Mehdi Methemmem, Soudani Marghli, Semir Nouira, Great Network
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?